Lepu Biopharma Co., Ltd.

Asia & Pacific Legal Chronicle. March 9, 2023

Lepu Biopharma and Keymed Biosciences’ Licensing Agreement with AstraZeneca AB

By Maha Kanaan

Zhong Lun advised Lepu Bio on the deal while Sidley represented Keymed Biosciences. Lepu Biopharma Co., Ltd and Keymed Biosciences Inc. signed a global exclusive license agreement...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Asia & Pacific Legal Chronicle. February 26, 2022

Lepu Biopharma’s US$116.1 Million Hong Kong IPO and Listing

By Giulia Di Palma

Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

BigHat Biosciences’ Licensing Collaboration With Synaffix B.V.

Zai Lab’s $200 Million Secondary Offering

LandBridge’s $245 Million Acquisition of Vitol’s Delaware Basin Assets

Grupo Pegasus’ Acquisition of Habitat Adulto Mayor

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

EQT Ventures’ Investment in Pruna AI

Baker McKenzie’s advice to the sellers of the shares in the company

Miniclip’s $1.2 Billion Acquisition of Easybrain

Landmark Developments’ Real Estate Financing

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Ministry of Finance of the People’s Republic of China (MOF)’s $2 Billion Sovereign Bond Issuance

Agro Tech Foods’ Acquisition of Del Monte Foods

Catbus Infolabs’ Bridge Financing Facilities

Hinshaw Adds Consumer Financial Services Partner Brian Turetsky in New York

Martim Della Valle is the new nominal partner of Marchini, Botelho e Caselta Advogados

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Hinshaw Adds Consumer Financial Services Partner Brian Turetsky in New York

Martim Della Valle is the new nominal partner of Marchini, Botelho e Caselta Advogados

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Lepu Biopharma and Keymed Biosciences’ Licensing Agreement with AstraZeneca AB

Standard 1 Year Membership Required

Lepu Biopharma’s US$116.1 Million Hong Kong IPO and Listing

Standard 1 Year Membership Required